As filed with the Securities and Exchange Commission on March 25, 2008
Registration No. 333-111132
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
Post-Effective Amendment No. 1 to Form F-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
____________________
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
(Exact name of Registrant as specified in its charter and translation of
Registrant's name into English)
Israel N/A
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
5 Basel Street
P.O. Box 3190
Petach Tikva 49131 Israel
972-3-926-7267
(Address and telephone number of Registrant's
principal executive offices)
Teva Pharmaceutical USA, Inc.
1090 Horsham Road
North Wales, Pennsylvania 19454
Attention: William S. Marth
(215) 591-3000
(Name, address and telephone number of agent for service)
with copies to:
Peter H. Jakes Thomas E. Sparks, Jr.
Jeffrey S. Hochman Pillsbury Winthrop LLP
Willkie Farr & Gallagher LLP 50 Freemont Street
787 Seventh Avenue San Francisco, California 94105-2228
New York, New York 10019-6099 (415) 983-1000
(212) 728-8000
Alan Klein, Jr.
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, New York 10017-3954
(212) 455-2000
Approximate date of commencement of proposed sale to the public: From time
to time as soon as practicable after this Registration Statement is declared
effective and all other conditions to the merger described in this Registration
Statement are satisfied.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. |_|
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. |X|
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|
_________________________
DEREGISTRATION OF UNSOLD SECURITIES
_________________________
This Post-Effective Amendment No. 1 to Form F-3 Registration Statement
relates to the Registration Statement on Form F-3 (File No. 333-111132) filed
with the Securities and Exchange Commission on December 12, 2003 (the
"Registration Statement") by Teva Pharmaceutical Industries Limited ("Teva"),
relating to the registration of 8,701,610 American Depositary Receipts ("ADRs")
evidencing American Depositary Shares, each representing one ordinary share, par
value 0.10 NIS, of Teva (after giving effect to the two-for-one stock split of
the ordinary shares in June 2004), that may be offered and sold from time to
time by the selling stockholders named in the Registration Statement. All ADRs
previously registered under the Registration Statement that remain unsold are
hereby withdrawn from registration.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form F-3 and has duly caused this Post-Effective
Amendment No. 1 to the Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Petach Tikva, Israel, on
March 25, 2008.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
By: /s/ Shlomo Yanai
-----------------------------------
Shlomo Yanai
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Post-Effective Amendment No. 1 to the Registration Statement has been
signed by the following persons in the capacities and on the dates indicated.
Name Title(s) Date
---------------------------------------- -------------------------------------- --------------------------------------
* Chairman March 25, 2008
----------------------------------------
Eli Hurvitz
/s/ Shlomo Yanai President and Chief Executive March 25, 2008
----------------------------------------- Officer
Shlomo Yanai
/s/ Dan S. Suesskind Chief Financial Officer March 25, 2008
---------------------------------------- (Principal Financial Officer and
Dan S. Suesskind Principal Accounting Officer)
Vice Chairman March __, 2008
----------------------------------------
Dr. Phillip Frost
Director March __, 2008
----------------------------------------
Roger Abravanel
* Director March 25, 2008
----------------------------------------
Ruth Cheshin
* Director March 25, 2008
----------------------------------------
Abraham E. Cohen
* Director March 25, 2008
----------------------------------------
Meir Heth
Director March __, 2008
----------------------------------------
Roger D. Kornberg
* Director March 25, 2008
----------------------------------------
Moshe Many
* Director March 25, 2008
----------------------------------------
Leora Meridor
Director March __, 2008
----------------------------------------
Dan Propper
* Director March 25, 2008
----------------------------------------
Max Reis
Director March __, 2008
----------------------------------------
Michael Sela
* Director March 25, 2008
----------------------------------------
Dov Shafir
* Director March 25, 2008
----------------------------------------
Gabriela Shalev
Director March __, 2008
----------------------------------------
David Shamir
* Director March 25, 2008
----------------------------------------
Harold Snyder
/s/ William S. Marth Authorized U.S. Representative March 25, 2008
----------------------------------------
William S. Marth
*By: /s/ Dan S. Suesskind
----------------------------------------
Dan S. Suesskind
Attorney-in-Fact